Susan Fugate

Summary

Affiliation: University of Oklahoma Health Sciences Center
Country: USA

Publications

  1. ncbi Levofloxacin and warfarin interaction
    Cade B Jones
    The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, USA
    Ann Pharmacother 36:1554-7. 2002
  2. ncbi Nonestrogen treatment modalities for vasomotor symptoms associated with menopause
    Susan E Fugate
    Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190 5040, USA
    Ann Pharmacother 38:1482-99. 2004
  3. ncbi Resistance to oral vitamin K for reversal of overanticoagulation during Crohn's disease relapse
    Susan Elaine Fugate
    The University of Oklahoma Health Sciences Center, Department of Pharmacy, Clinical and Administrative Sciences, Oklahoma City, OK 73190 5040, USA
    J Thromb Thrombolysis 17:219-23. 2004
  4. ncbi Impaired warfarin response secondary to high-dose vitamin K1 for rapid anticoagulation reversal: case series and literature review
    Susan E Fugate
    Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190 5040, USA
    Pharmacotherapy 24:1213-20. 2004
  5. ncbi Standardizing the management of heparin-induced thrombocytopenia
    Susan Fugate
    Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma, 1110 North Stonewall, P O Box 26901, Oklahoma City, OK 73126, USA
    Am J Health Syst Pharm 65:334-9. 2008
  6. ncbi Cangrelor for treatment of coronary thrombosis
    Susan E Fugate
    College of Pharmacy, University of Oklahoma, Oklahoma City, OK 73190 5040, USA
    Ann Pharmacother 40:925-30. 2006
  7. ncbi Using team-based learning in an endocrine module taught across two campuses
    Nancy A Letassy
    College of Pharmacy, University of Oklahoma, Oklahoma City, OK 73126 0901, USA
    Am J Pharm Educ 72:103. 2008
  8. ncbi Effect of oral corticosteroids on chronic warfarin therapy
    Kathleen A Hazlewood
    College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190-5040, USA
    Ann Pharmacother 40:2101-6. 2006
  9. ncbi Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy
    David A Davis
    Department of Pharmacy, Veterans Affairs Medical Center, Oklahoma City, Oklahoma 73190-5040, USA
    Pharmacotherapy 25:442-7. 2005
  10. ncbi Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction
    Edna Patatanian
    Department of Pharmacy Practice, College of Pharmacy, Southwestern Oklahoma State University, Oklahoma City, OK 73103 2600, USA
    Ann Pharmacother 40:2205-10. 2006

Collaborators

Detail Information

Publications11

  1. ncbi Levofloxacin and warfarin interaction
    Cade B Jones
    The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, USA
    Ann Pharmacother 36:1554-7. 2002
    ..Our case studies demonstrate significant elevations in INR values during and up to 1 day after levofloxacin therapy in patients undergoing stable warfarin therapy...
  2. ncbi Nonestrogen treatment modalities for vasomotor symptoms associated with menopause
    Susan E Fugate
    Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190 5040, USA
    Ann Pharmacother 38:1482-99. 2004
    ..To systematically review the literature regarding the efficacy and safety of nonestrogen treatments for menopause-associated vasomotor symptoms not due to cancer or chemotherapy...
  3. ncbi Resistance to oral vitamin K for reversal of overanticoagulation during Crohn's disease relapse
    Susan Elaine Fugate
    The University of Oklahoma Health Sciences Center, Department of Pharmacy, Clinical and Administrative Sciences, Oklahoma City, OK 73190 5040, USA
    J Thromb Thrombolysis 17:219-23. 2004
    ..Additionally, a literature review was conducted to explore the mechanism and supporting evidence for poor response to oral vitamin K during CD relapse...
  4. ncbi Impaired warfarin response secondary to high-dose vitamin K1 for rapid anticoagulation reversal: case series and literature review
    Susan E Fugate
    Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190 5040, USA
    Pharmacotherapy 24:1213-20. 2004
    ..We reviewed the literature to examine the mechanism of impaired warfarin response, and the clinical efficacy, safety, and appropriateness of vitamin K1 and fresh-frozen plasma in urgent reversal of anticoagulation...
  5. ncbi Standardizing the management of heparin-induced thrombocytopenia
    Susan Fugate
    Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma, 1110 North Stonewall, P O Box 26901, Oklahoma City, OK 73126, USA
    Am J Health Syst Pharm 65:334-9. 2008
    ..An evidence-based heparin- induced thrombocytopenia (HIT) treatment protocol to standardize the management of confirmed or suspected HIT was developed...
  6. ncbi Cangrelor for treatment of coronary thrombosis
    Susan E Fugate
    College of Pharmacy, University of Oklahoma, Oklahoma City, OK 73190 5040, USA
    Ann Pharmacother 40:925-30. 2006
    ....
  7. ncbi Using team-based learning in an endocrine module taught across two campuses
    Nancy A Letassy
    College of Pharmacy, University of Oklahoma, Oklahoma City, OK 73126 0901, USA
    Am J Pharm Educ 72:103. 2008
    ..To implement a team-based learning (TBL) format in an endocrine module to promote students' active learning in a course delivered to 2 campuses...
  8. ncbi Effect of oral corticosteroids on chronic warfarin therapy
    Kathleen A Hazlewood
    College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190-5040, USA
    Ann Pharmacother 40:2101-6. 2006
    ..CONCLUSIONS: Use of oral corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction...
  9. ncbi Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy
    David A Davis
    Department of Pharmacy, Veterans Affairs Medical Center, Oklahoma City, Oklahoma 73190-5040, USA
    Pharmacotherapy 25:442-7. 2005
    ..In addition, patients should be closely monitored for a possible delayed interaction that may occur with each repeated cycle of 5-fluorouracil chemotherapy...
  10. ncbi Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction
    Edna Patatanian
    Department of Pharmacy Practice, College of Pharmacy, Southwestern Oklahoma State University, Oklahoma City, OK 73103 2600, USA
    Ann Pharmacother 40:2205-10. 2006
    ..To evaluate the efficacy and safety of local acting hemostatic agents in patients who are undergoing dental extraction(s) and are taking oral anticoagulants...
  11. ncbi Thiazolidinediones for treatment of polycystic ovary syndrome
    Dena L Stout
    Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma Health Sciences Center College of Pharmacy, Oklahoma City, Oklahoma 73190-5040, USA
    Pharmacotherapy 25:244-52. 2005
    ..CONCLUSION: Pioglitazone and rosiglitazone should be considered a second-line treatment alternative to metformin for management of women with PCOS who are resistant to insulin or who are obese...